Biotech Values

[mouton29]

<< the likelihood of Teva’s getting a PI will be diminished if the Judge believes Teva is unlikely to prevail in the Copaxone trial.>>

Indeed. But switching sides, if MNTA seeks a preliminary injunction against TEVA in the MNTA Lovenox infringement litigation, will MNTA be able to establish that it is likely to prevail on the merits without the discovery that won't be concluded till November 2012?